Cancer cell vivo inhibitory. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy15

Cell Line, Tumor Tumor Cells, Cultured HCT116 Cells MCF-7 Cells HT29 Cells Neoplastic Stem Cells Breast Cell Line Prostate Epithelial Cells HeLa Cells Cell Nucleus Neoplastic Cells, Circulating Spheroids, Cellular Mitochondria

Organisms4

Mice, Nude Mice, SCID Mice, Inbred BALB C Adenoviridae

Diseases40

Breast Neoplasms Colonic Neoplasms Neoplasm Invasiveness Ovarian Neoplasms Neoplasms Lung Neoplasms Pancreatic Neoplasms Neoplasm Metastasis Stomach Neoplasms Prostatic Neoplasms Carcinoma Colorectal Neoplasms Adenocarcinoma Urinary Bladder Neoplasms Carcinoma, Non-Small-Cell Lung Cell Transformation, Neoplastic Uterine Cervical Neoplasms Disease Progression Carcinoma, Squamous Cell Neoplasms, Hormone-Dependent Endometrial Neoplasms Genetic Predisposition to Disease Neovascularization, Pathologic Carcinoma, Small Cell Liver Neoplasms Bone Neoplasms Esophageal Neoplasms Neoplasm Recurrence, Local Mammary Neoplasms, Experimental Neoplasms, Glandular and Epithelial Rectal Neoplasms Mouth Neoplasms Head and Neck Neoplasms Carcinoma, Pancreatic Ductal Neoplasms, Experimental Neoplastic Cells, Circulating Thyroid Neoplasms Gastrointestinal Neoplasms Skin Neoplasms Melanoma

Chemicals and Drugs86

Antineoplastic Agents RNA, Small Interfering Neoplasm Proteins RNA, Messenger Antineoplastic Agents, Phytogenic Tumor Suppressor Protein p53 Receptors, Estrogen Receptor, erbB-2 Tumor Markers, Biological DNA, Neoplasm Proto-Oncogene Proteins c-akt Cancer Vaccines Tamoxifen Cisplatin Receptor, Epidermal Growth Factor Receptors, Androgen Anticarcinogenic Agents Paclitaxel RNA, Neoplasm MicroRNAs Androgens Tumor Suppressor Proteins Proto-Oncogene Proteins c-bcl-2 Estrogen Receptor alpha Proto-Oncogene Proteins Transcription Factors Enzyme Inhibitors Antigens, Neoplasm DNA-Binding Proteins Prostate-Specific Antigen Apoptosis Regulatory Proteins Caspase 3 Protein-Serine-Threonine Kinases Caspases Fluorouracil Antibodies, Monoclonal Protein Kinase Inhibitors Receptors, Progesterone Antimetabolites, Antineoplastic Antineoplastic Agents, Hormonal Inhibitor of Apoptosis Proteins Antibiotics, Antineoplastic beta Catenin Estrogens Nuclear Proteins Cadherins Cyclin-Dependent Kinase Inhibitor p21 Estrogen Antagonists Phosphatidylinositol 3-Kinases Estradiol Plant Extracts Cyclin D1 Cell Cycle Proteins DNA Primers Quinazolines Hydroxamic Acids Membrane Proteins Deoxycytidine TNF-Related Apoptosis-Inducing Ligand Poly(ADP-ribose) Polymerases bcl-2-Associated X Protein Azacitidine NF-kappa B Estrogen Receptor Modulators Histone Deacetylase Inhibitors Indoles Cyclooxygenase 2 Reactive Oxygen Species TOR Serine-Threonine Kinases Taxoids Antibodies, Monoclonal, Humanized Vascular Endothelial Growth Factor A PTEN Phosphohydrolase Antigens, CD44 Telomerase Proto-Oncogene Proteins c-myc Extracellular Signal-Regulated MAP Kinases Nitriles STAT3 Transcription Factor Radiation-Sensitizing Agents Curcumin Carrier Proteins ras Proteins BRCA1 Protein Luciferases Adaptor Proteins, Signal Transducing

Analytical, Diagnostic and Therapeutic Techniques and Equipment50

Early Detection of Cancer Xenograft Model Antitumor Assays Reverse Transcriptase Polymerase Chain Reaction Blotting, Western Drug Screening Assays, Antitumor Neoplasm Transplantation Transfection Transplantation, Heterologous Gene Expression Profiling Gene Knockdown Techniques Flow Cytometry Antineoplastic Combined Chemotherapy Protocols Prognosis Oligonucleotide Array Sequence Analysis Tumor Burden Survival Analysis Immunohistochemistry Inhibitory Concentration 50 Survival Rate Molecular Targeted Therapy Models, Biological Neoplasm Staging Tumor Stem Cell Assay Risk Follow-Up Studies Retrospective Studies Combined Modality Therapy Real-Time Polymerase Chain Reaction Registries Mammary Neoplasms, Experimental Prospective Studies Genetic Therapy Immunoblotting Disease-Free Survival Risk Assessment Drug Delivery Systems Immunoenzyme Techniques Tissue Array Analysis Sensitivity and Specificity Kaplan-Meier Estimate Chemotherapy, Adjuvant Immunoprecipitation Odds Ratio Neoplasms, Experimental Multivariate Analysis Reproducibility of Results Clinical Trials as Topic Risk Factors Mammography Neoplasm Grading

Psychiatry and Psychology1

Phenomena and Processes58

Gene Expression Regulation, Neoplastic Apoptosis Cell Proliferation Drug Resistance, Neoplasm Cell Survival Cell Movement Signal Transduction Cell Division Down-Regulation Cell Cycle Transfection RNA Interference Cell Growth Processes Up-Regulation Promoter Regions, Genetic Dose-Response Relationship, Drug Gene Silencing Phosphorylation Drug Synergism Mutation Inhibitory Concentration 50 Gene Expression Base Sequence Genetic Predisposition to Disease Epithelial-Mesenchymal Transition Enzyme Activation Transcription, Genetic Genes, Tumor Suppressor Cell Adhesion Risk Cell Death Radiation Tolerance Tumor Microenvironment Phenotype Protein Binding DNA Damage Genes, Neoplasm Genes, p53 Sensitivity and Specificity Time Factors Transcriptional Activation Odds Ratio Genes, BRCA1 Epigenesis, Genetic DNA Methylation Autophagy Genotype Drug Resistance, Multiple Genetic Vectors MAP Kinase Signaling System Gene Expression Regulation, Enzymologic Cell Cycle Checkpoints Genes, ras Cell Hypoxia G1 Phase Polymorphism, Genetic G2 Phase Cell Cycle Checkpoints Gene Amplification

Disciplines and Occupations2

Immunohistochemistry Medical Oncology

Anthropology, Education, Sociology and Social Phenomena1

National Cancer Institute (U.S.)

Information Science4

Survival Rate Base Sequence Molecular Sequence Data Registries

Named Groups1

Health Care18

Survival Analysis Survival Rate National Cancer Institute (U.S.)Risk Follow-Up Studies Retrospective Studies Registries Prospective Studies Disease-Free Survival Risk Assessment Sensitivity and Specificity Kaplan-Meier Estimate Age Factors Odds Ratio Multivariate Analysis Reproducibility of Results Clinical Trials as Topic Risk Factors

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Information Science Named Groups Health Care Geographicals

Breast Neoplasms Gene Expression Regulation, Neoplastic Cell Line, Tumor Tumor Cells, Cultured Colonic Neoplasms Apoptosis Cell Proliferation Mice, Nude Antineoplastic Agents Neoplasm Invasiveness Ovarian Neoplasms Neoplasms Lung Neoplasms Early Detection of Cancer Pancreatic Neoplasms Drug Resistance, Neoplasm RNA, Small Interfering Neoplasm Metastasis Stomach Neoplasms Cell Survival Neoplasm Proteins Xenograft Model Antitumor Assays Reverse Transcriptase Polymerase Chain Reaction Blotting, Western RNA, Messenger Drug Screening Assays, Antitumor Cell Movement Signal Transduction Cell Division Down-Regulation Cell Cycle Neoplasm Transplantation HCT116 Cells Transfection MCF-7 Cells RNA Interference Cell Growth Processes Transplantation, Heterologous HT29 Cells Prostatic Neoplasms Antineoplastic Agents, Phytogenic Gene Expression Profiling Tumor Suppressor Protein p53 Carcinoma Colorectal Neoplasms Adenocarcinoma Receptors, Estrogen Receptor, erbB-2 Urinary Bladder Neoplasms Up-Regulation Tumor Markers, Biological Promoter Regions, Genetic Carcinoma, Non-Small-Cell Lung Dose-Response Relationship, Drug Cell Transformation, Neoplastic Gene Silencing Gene Knockdown Techniques Uterine Cervical Neoplasms Phosphorylation DNA, Neoplasm Drug Synergism Disease Progression Proto-Oncogene Proteins c-akt Flow Cytometry Cancer Vaccines Mutation Carcinoma, Squamous Cell Tamoxifen Cisplatin Receptor, Epidermal Growth Factor Antineoplastic Combined Chemotherapy Protocols Mice, SCID Neoplastic Stem Cells Prognosis Neoplasms, Hormone-Dependent Oligonucleotide Array Sequence Analysis Receptors, Androgen Tumor Burden Anticarcinogenic Agents Paclitaxel RNA, Neoplasm MicroRNAs Survival Analysis Androgens Tumor Suppressor Proteins Immunohistochemistry Inhibitory Concentration 50 Survival Rate Proto-Oncogene Proteins c-bcl-2 Gene Expression Base Sequence Estrogen Receptor alpha Proto-Oncogene Proteins Transcription Factors Endometrial Neoplasms Genetic Predisposition to Disease Breast Neovascularization, Pathologic Molecular Targeted Therapy Epithelial-Mesenchymal Transition

No FAQ available that match "cancer cell vivo inhibitory"